APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Desvenlafaxine Succinate Extended-release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Desvenlafaxine Succinate Extended-release Tablets Industry Growth and Trends Forecast to 2032

Report ID 173983760120 December 202579 pages

Choose your research edition.

Industry ResearchDesvenlafaxine Succinate Extended-release Tablets Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Desvenlafaxine Succinate Extended-release Tablets Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Desvenlafaxine Succinate Extended-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Desvenlafaxine Succinate Extended-release Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Desvenlafaxine Succinate Extended-release Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Desvenlafaxine Succinate Extended-release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Desvenlafaxine Succinate Extended-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Desvenlafaxine Succinate Extended-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Desvenlafaxine Succinate Extended-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Desvenlafaxine Succinate Extended-release Tablets include Yichang Humanwell Pharmaceutical, CSPC Pharmaceutical Group and PF Prism CV (Pfizer), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Desvenlafaxine Succinate Extended-release Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Desvenlafaxine Succinate Extended-release Tablets market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Desvenlafaxine Succinate Extended-release Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Desvenlafaxine Succinate Extended-release Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Desvenlafaxine Succinate Extended-release Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Desvenlafaxine Succinate Extended-release Tablets Market by Company

Yichang Humanwell Pharmaceutical

CSPC Pharmaceutical Group

PF Prism CV (Pfizer)

Desvenlafaxine Succinate Extended-release Tablets Segment by Type

50mg

25mg

100mg

Desvenlafaxine Succinate Extended-release Tablets Segment by Application

Clinic

Hospital

Pharmacy

Desvenlafaxine Succinate Extended-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desvenlafaxine Succinate Extended-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Desvenlafaxine Succinate Extended-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desvenlafaxine Succinate Extended-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Desvenlafaxine Succinate Extended-release Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Desvenlafaxine Succinate Extended-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg Table 2. Major Company of 25mg Table 3. Major Company of 100mg Table 4. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 6. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type (2021-2026) Table 9. Global Desvenlafaxine Succinate Extended-release Tablets Price by Type (2021-2026) & (US$/unit) Table 10. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2027-2032) & (units) Table 11. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type (2027-2032) Table 14. Global Desvenlafaxine Succinate Extended-release Tablets Price by Type (2027-2032) & (US$/unit) Table 15. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 16. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 18. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 20. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 22. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (units) Table 24. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Desvenlafaxine Succinate Extended-release Tablets Industry Trends Table 26. Desvenlafaxine Succinate Extended-release Tablets Industry Drivers Table 27. Desvenlafaxine Succinate Extended-release Tablets Industry Opportunities and Challenges Table 28. Desvenlafaxine Succinate Extended-release Tablets Industry Restraints Table 29. Global Desvenlafaxine Succinate Extended-release Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Desvenlafaxine Succinate Extended-release Tablets Revenue Market Share by Company (2021-2026) Table 31. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Company (2021-2026) & (units) Table 32. Global Desvenlafaxine Succinate Extended-release Tablets Sales Share by Company (2021-2026) Table 33. Global Desvenlafaxine Succinate Extended-release Tablets Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Desvenlafaxine Succinate Extended-release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Desvenlafaxine Succinate Extended-release Tablets Major Company Production Sites and Headquarters Table 36. Global Desvenlafaxine Succinate Extended-release Tablets Company, Product Type & Application Table 37. Global Desvenlafaxine Succinate Extended-release Tablets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Desvenlafaxine Succinate Extended-release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Desvenlafaxine Succinate Extended-release Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Region (2021-2026) & (units) Table 42. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Region (2021-2026) Table 45. Global Desvenlafaxine Succinate Extended-release Tablets Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Region (2027-2032) & (units) Table 47. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Region (2027-2032) Table 50. Global Desvenlafaxine Succinate Extended-release Tablets Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 53. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application (2021-2026) Table 56. Global Desvenlafaxine Succinate Extended-release Tablets Price by Application (2021-2026) & (US$/unit) Table 57. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2027-2032) & (units) Table 58. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application (2027-2032) Table 61. Global Desvenlafaxine Succinate Extended-release Tablets Price by Application (2027-2032) & (US$/unit) Table 62. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 63. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 65. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 67. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 69. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (units) Table 71. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. Yichang Humanwell Pharmaceutical Company Information Table 73. Yichang Humanwell Pharmaceutical Business Overview Table 74. Yichang Humanwell Pharmaceutical Desvenlafaxine Succinate Extended-release Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Yichang Humanwell Pharmaceutical Desvenlafaxine Succinate Extended-release Tablets Product Portfolio Table 76. Yichang Humanwell Pharmaceutical Recent Development Table 77. CSPC Pharmaceutical Group Company Information Table 78. CSPC Pharmaceutical Group Business Overview Table 79. CSPC Pharmaceutical Group Desvenlafaxine Succinate Extended-release Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. CSPC Pharmaceutical Group Desvenlafaxine Succinate Extended-release Tablets Product Portfolio Table 81. CSPC Pharmaceutical Group Recent Development Table 82. PF Prism CV (Pfizer) Company Information Table 83. PF Prism CV (Pfizer) Business Overview Table 84. PF Prism CV (Pfizer) Desvenlafaxine Succinate Extended-release Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. PF Prism CV (Pfizer) Desvenlafaxine Succinate Extended-release Tablets Product Portfolio Table 86. PF Prism CV (Pfizer) Recent Development Table 87. North America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 88. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026) & (units) Table 89. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share by Country (2021-2026) Table 90. North America Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032) & (units) Table 91. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 92. North America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Desvenlafaxine Succinate Extended-release Tablets Market Share by Country (2021-2026) Table 95. North America Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Desvenlafaxine Succinate Extended-release Tablets Market Share Forecast by Country (2027-2032) Table 97. Europe Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 98. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026) & (units) Table 99. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share by Country (2021-2026) Table 100. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032) & (units) Table 101. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Desvenlafaxine Succinate Extended-release Tablets Market Share by Country (2021-2026) Table 105. Europe Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Desvenlafaxine Succinate Extended-release Tablets Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026) & (units) Table 109. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032) & (units) Table 111. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Share by Country (2021-2026) Table 115. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Share Forecast by Country (2027-2032) Table 117. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 118. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026) & (units) Table 119. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share by Country (2021-2026) Table 120. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032) & (units) Table 121. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Share by Country (2021-2026) Table 125. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026) & (units) Table 129. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032) & (units) Table 131. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Share by Country (2021-2026) Table 135. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Desvenlafaxine Succinate Extended-release Tablets Distributors List Table 140. Desvenlafaxine Succinate Extended-release Tablets Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Desvenlafaxine Succinate Extended-release Tablets Image Figure 2. Global Desvenlafaxine Succinate Extended-release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Desvenlafaxine Succinate Extended-release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Desvenlafaxine Succinate Extended-release Tablets Sales (2021-2032) & (units) Figure 5. 50mg Image Figure 6. Global 50mg Sales YoY Growth (2021-2032) & (units) Figure 7. 25mg Image Figure 8. Global 25mg Sales YoY Growth (2021-2032) & (units) Figure 9. 100mg Image Figure 10. Global 100mg Sales YoY Growth (2021-2032) & (units) Figure 11. Global Desvenlafaxine Succinate Extended-release Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Desvenlafaxine Succinate Extended-release Tablets Market Share by Type 2025 VS 2032 Figure 13. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type in 2025 Figure 14. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type in 2025 Figure 15. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Desvenlafaxine Succinate Extended-release Tablets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (units) Figure 31. Global Desvenlafaxine Succinate Extended-release Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Desvenlafaxine Succinate Extended-release Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Desvenlafaxine Succinate Extended-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. North America Desvenlafaxine Succinate Extended-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Desvenlafaxine Succinate Extended-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Europe Desvenlafaxine Succinate Extended-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Desvenlafaxine Succinate Extended-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Desvenlafaxine Succinate Extended-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Latin America Desvenlafaxine Succinate Extended-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Desvenlafaxine Succinate Extended-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 60. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Desvenlafaxine Succinate Extended-release Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Desvenlafaxine Succinate Extended-release Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 25mg
  • 100mg
Applications
  • Clinic
  • Hospital
  • Pharmacy
Companies covered
  • Yichang Humanwell Pharmaceutical
  • CSPC Pharmaceutical Group
  • PF Prism CV (Pfizer)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Desvenlafaxine Succinate Extended-release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Desvenlafaxine Succinate Extended-release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Desvenlafaxine Succinate Extended-release Tablets Market by Type
  6. 1.3.1 50mg
  7. 1.3.2 25mg
  8. 1.3.3 100mg
  9. 1.4 Global Desvenlafaxine Succinate Extended-release Tablets Market Size by Type
  10. 1.4.1 Global Desvenlafaxine Succinate Extended-release Tablets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Desvenlafaxine Succinate Extended-release Tablets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Desvenlafaxine Succinate Extended-release Tablets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Desvenlafaxine Succinate Extended-release Tablets Industry Trends
  2. 2.2 Desvenlafaxine Succinate Extended-release Tablets Industry Drivers
  3. 2.3 Desvenlafaxine Succinate Extended-release Tablets Industry Opportunities and Challenges
  4. 2.4 Desvenlafaxine Succinate Extended-release Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Desvenlafaxine Succinate Extended-release Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Desvenlafaxine Succinate Extended-release Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Desvenlafaxine Succinate Extended-release Tablets Price (2021-2026)
  4. 3.4 Global Desvenlafaxine Succinate Extended-release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Desvenlafaxine Succinate Extended-release Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Desvenlafaxine Succinate Extended-release Tablets Company, Product Type & Application
  7. 3.7 Global Desvenlafaxine Succinate Extended-release Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Desvenlafaxine Succinate Extended-release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Desvenlafaxine Succinate Extended-release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Desvenlafaxine Succinate Extended-release Tablets Tier 1, Tier 2, and Tier 3
4 Desvenlafaxine Succinate Extended-release Tablets Regional Status and Outlook
  1. 4.1 Global Desvenlafaxine Succinate Extended-release Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Desvenlafaxine Succinate Extended-release Tablets Historic Market Size by Region
  3. 4.2.1 Global Desvenlafaxine Succinate Extended-release Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Desvenlafaxine Succinate Extended-release Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Desvenlafaxine Succinate Extended-release Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Desvenlafaxine Succinate Extended-release Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Desvenlafaxine Succinate Extended-release Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Desvenlafaxine Succinate Extended-release Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Desvenlafaxine Succinate Extended-release Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Desvenlafaxine Succinate Extended-release Tablets by Application
  1. 5.1 Desvenlafaxine Succinate Extended-release Tablets Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.2 Global Desvenlafaxine Succinate Extended-release Tablets Market Size by Application
  6. 5.2.1 Global Desvenlafaxine Succinate Extended-release Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Desvenlafaxine Succinate Extended-release Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Desvenlafaxine Succinate Extended-release Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yichang Humanwell Pharmaceutical
  2. 6.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 6.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 6.1.3 Yichang Humanwell Pharmaceutical Desvenlafaxine Succinate Extended-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yichang Humanwell Pharmaceutical Desvenlafaxine Succinate Extended-release Tablets Product Portfolio
  6. 6.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 6.2 CSPC Pharmaceutical Group
  8. 6.2.1 CSPC Pharmaceutical Group Company Information
  9. 6.2.2 CSPC Pharmaceutical Group Business Overview
  10. 6.2.3 CSPC Pharmaceutical Group Desvenlafaxine Succinate Extended-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Pharmaceutical Group Desvenlafaxine Succinate Extended-release Tablets Product Portfolio
  12. 6.2.5 CSPC Pharmaceutical Group Recent Developments
  13. 6.3 PF Prism CV (Pfizer)
  14. 6.3.1 PF Prism CV (Pfizer) Company Information
  15. 6.3.2 PF Prism CV (Pfizer) Business Overview
  16. 6.3.3 PF Prism CV (Pfizer) Desvenlafaxine Succinate Extended-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PF Prism CV (Pfizer) Desvenlafaxine Succinate Extended-release Tablets Product Portfolio
  18. 6.3.5 PF Prism CV (Pfizer) Recent Developments
7 North America by Country
  1. 7.1 North America Desvenlafaxine Succinate Extended-release Tablets Sales by Country
  2. 7.1.1 North America Desvenlafaxine Succinate Extended-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country
  6. 7.2.1 North America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Country
  2. 8.1.1 Europe Desvenlafaxine Succinate Extended-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Desvenlafaxine Succinate Extended-release Tablets Market Size by Country
  6. 8.2.1 Europe Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Desvenlafaxine Succinate Extended-release Tablets Sales by Country
  2. 10.1.1 South America Desvenlafaxine Succinate Extended-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country
  6. 10.2.1 South America Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Desvenlafaxine Succinate Extended-release Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Desvenlafaxine Succinate Extended-release Tablets Value Chain Analysis
  2. 12.1.1 Desvenlafaxine Succinate Extended-release Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Desvenlafaxine Succinate Extended-release Tablets Production Mode & Process
  7. 12.2 Desvenlafaxine Succinate Extended-release Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Desvenlafaxine Succinate Extended-release Tablets Distributors
  10. 12.2.3 Desvenlafaxine Succinate Extended-release Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst